Article
[Molecularly Targeted Therapy for Craniopharyngioma].
No shinkei geka. Neurological surgery - 1 Jan 2022
Tanaka Shota, Takayanagi Shunsaku, Takami Hirokazu, Saito Nobuhito
Abstract excerpt
Craniopharyngioma is a pathologically benign but clinically malignant brain tumor typically located in the parasellar region. It is treated by surgical resection, but in most cases, total removal is not amenable due to its adhesion to the adjacent vital structures, such as the optic nerve, hypothalamus, and pituitary stalk. Often, tumor regrowth or recurrence occursand it is usually treated with either...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
